Suven Pharmaceuticals’ Wholly Owned Subsidiary -- Casper Pharma’s formulations manufacturing facility has received the Establishment Inspection Report (EIR) from United States Food & Drug Administration (USFDA).
The USFDA has categorized the inspection as Voluntary Action Indicated (VAI) and has deemed it as closed under 21 CFR 20.64(d)(3).
Suven Pharmaceuticals is a bio-pharmaceutical company, incorporated with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.
